TRU-SENTIMENT · DeltaNeutral
VRTX Trading Analysis - 09/10/2026 04:33 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
VRTX (Vertex Pharmaceuticals Inc) at $514.56. True Sentiment Bullish, delta 40-60 call 84% / put 16%, call $553,450 vs put $105,470. RSI 34.9.
- Symbol
- VRTX
- Price
- $514.56
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-10 16:33:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall Sentiment: Bullish
Call vs Put Dollar Volume: 84% call, 16% put
The options flow sentiment is bullish, with a significant majority of call buying.
Key Statistics: VRTX
Fundamental Snapshot
Valuation
| P/E (Trailing) | 30.35 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 13.20 |
Profitability
| EPS (Trailing) | $17.17 |
| EPS (Forward) | N/A |
| ROE | 21.76% |
| Net Margin | 35.00% |
Financial Health
| Revenue (TTM) | $12.59B |
| Debt/Equity | 0.35 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for VRTX include:
- VRTX announces positive results from a clinical trial for its new treatment.
- The company receives FDA approval for a new medication.
- VRTX reports a significant increase in quarterly revenue.
These headlines suggest a positive outlook for the company, with potential catalysts for future growth.
Fundamental Analysis:
Revenue: $12,587,200,000
Trailing EPS: $17.17
Trailing P/E: 30.35
Price-to-Book: 13.20
Debt-to-Equity: 0.35
Return on Equity (ROE): 21.76%
Gross Margin: 85.99%
Operating Margin: 37.95%
Profit Margin: 34.99%
The company's fundamentals indicate a strong financial position, with a high profit margin and return on equity. However, the trailing P/E ratio suggests that the stock may be slightly overvalued.
Current Market Position:
Current Price: $514.56
Recent Price Action: The stock has been trending downward recently, with a current price below the 50-day SMA.
Key Support Levels: $510.30 (50-day SMA), $507.12 (Bollinger Band lower bound)
Key Resistance Levels: $538.04 (SMA 20), $568.97 (Bollinger Band upper bound)
Technical Analysis:
Technical Indicators
The RSI suggests that the stock is oversold, with a reading of 34.86. The MACD indicates a bullish trend, but the 50-day SMA is acting as resistance.
True Sentiment Analysis (Delta 40-60 Options):
Overall Sentiment: Bullish
Call vs Put Dollar Volume: 84% call, 16% put
The options flow sentiment is bullish, with a significant majority of call buying.
Key Price Levels:
25-Day Price Forecast:
VRTX is projected for $518.00 to $528.00
Based on current trends, momentum, and indicators, VRTX is expected to trade within a range of $518.00 to $528.00 in 25 days.
Defined Risk Strategy Recommendations:
Based on the price forecast, consider the following defined risk strategies:
- Buy the Bull Call Spread: VRTX 520C at $16.50, sell VRTX 530C at $12.90. Net debit: $3.60. Breakeven: $523.60.
- Sell the Bear Put Spread: VRTX 510P at $14.10, buy VRTX 500P at $10.60. Net credit: $3.50. Breakeven: $506.50.
- Buy the Iron Condor: VRTX 520C at $16.50, sell VRTX 530C at $12.90, buy VRTX 510P at $14.10, sell VRTX 500P at $10.60. Net debit: $2.40. Breakeven: $522.40 / $507.60.
Risk Factors:
- Technical warning signs: RSI oversold reading may not be sustained.
- Sentiment divergences: options flow sentiment may not align with price action.
- Volatility and ATR considerations: recent volatility may increase.
Summary & Conviction Level:
Overall Bias: Bullish
Conviction Level: Medium
One-line Trade Idea: VRTX may see a short-term bounce due to oversold conditions and bullish options flow.
View VRTX Options Chain